The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
The recent outbreak of the corona virus disease (COVID-19) has had major global impact. The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection and psychiatric diseases is of great concern, with an evident link between corona virus infections and various central...
Main Authors: | Esmé Jansen van Vuren, Stephan F. Steyn, Christiaan B. Brink, Marisa Möller, Francois P. Viljoen, Brian H. Harvey |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220313937 |
Similar Items
-
Using Pharmacological Clues to Untangle The Biology of a Complex Psychiatric Disorder: Depression
by: Ordway, Gregory A.
Published: (2006) -
Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
by: E. G. Mendelevich
Published: (2018-11-01) -
The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
by: Rosa Maria Vitale, et al.
Published: (2021-05-01) -
Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus
by: Alessandra Bortoluzzi, et al.
Published: (2018-03-01) -
Neuropsychiatric Presentations and Sequelae of COVID-19: Current Evidence and Research Recommendations
by: Way Hinn Chong, et al.
Published: (2020-11-01)